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PLINICAL RESEARCH Coronary Artery Disease
ngioscopic Follow-Up Study of
oronary Ruptured Plaques in Nonculprit Lesions
asamichi Takano, MD, Shigenobu Inami, MD, Fumiyuki Ishibashi, MD, Kentaro Okamatsu, MD,
oji Seimiya, MD, Takayoshi Ohba, MD, Shunta Sakai, MD, Kyoichi Mizuno, MD, PHD, FACC
hiba, Japan
OBJECTIVES Changes of ruptured plaques in nonculprit lesions were evaluated using coronary angioscopy.
BACKGROUND The concept of multiple coronary plaque ruptures has been established. However, no detailed
follow-up studies of ruptured plaques in nonculprit lesions have yet been reported.
METHODS Forty-eight thrombi in 50 ruptured coronary plaques in nonculprit lesions in 30 patients were
identified by angioscopy. The percent diameter stenosis (%DS) at the target plaques on
quantitative coronary angiographic analysis and the serum C-reactive protein (CRP) level
were measured.
RESULTS The mean angioscopic follow-up period was 13  9 months. Thirty-five superimposed thrombi
still remained at follow-up, and the predominant thrombus color changed from red (56%) at
baseline to pinkish-white (83%) at follow-up. The healing rate increased according to the
angioscopic follow-up period (23% at 12 months vs. 55% at 12 months, p  0.044). The
%DS at the healed plaque increased from baseline to follow-up (12.3  5.8% vs. 22.7  11.6%,
respectively; p  0.0004). The serum CRP level in patients with healed plaques (n  10) was
lower than that in those without healed plaques (n  19; 0.07  0.03 mg/dl vs. 0.15  0.11
mg/dl, respectively; p  0.007).
CONCLUSIONS The present study demonstrated that: 1) ruptured plaques in nonculprit lesions tend to heal
slowly with a progression of angiographic stenosis; and 2) the serum CRP level might reflect
the disease activity of the plaque ruptures. (J Am Coll Cardiol 2005;45:652–8) © 2005 by
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.09.077the American College of Cardiology Foundation
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ftherosclerotic coronary plaque rupture (or erosion) and
ubsequent thrombus formation in the culprit lesion are
ecognized to be the major motivating factors in acute
oronary syndrome (ACS) (1–5). Intravascular ultrasound
IVUS) studies recently reported that a plaque rupture
ccurs not only in culprit lesions but also in other athero-
clerotic plaques in patients with ACS, stable angina pec-
See page 659
oris (SAP), and silent myocardial ischemia (6–9). The
oncept of “pancoronaritis” or “multifocal plaque rupture”
as been established. In the clinical setting, ruptured plaque
n the culprit lesion is usually treated with percutaneous
oronary intervention (PCI), and the natural course of
uptured plaque without PCI has not yet been reported.
revious pathologic studies have shown that healed plaques
fter a subclinical rupture tend to result in increased nar-
owing of the coronary lumen (10,11). Nevertheless, rup-
ured plaques in nonculprit lesions have not been well
escribed as to whether they heal uneventfully with (or
ithout) luminal narrowing or lead to an occurrence of
cute coronary events in living patients.
From the Department of Internal Medicine, Chiba-Hokusoh Hospital, Nippon
edical School, Chiba, Japan.w
Manuscript received June 3, 2004; revised manuscript received September 8, 2004,
ccepted September 13, 2004.Serum C-reactive protein (CRP), a predictor of acute
yocardial infarction (MI), is expressed in human athero-
clerotic lesions, and most CRPs show an increased expres-
ion at sites of plaque rupture (12–14). The serial changes in
he serum CRP level in patients with multiple plaque
uptures have also not yet been elucidated.
Coronary angioscopy can provide direct images of the
ndoluminal surface and detailed information on plaque
upture (or healing), as well as on the existence and age of
thrombus. The purpose of this study was to investigate the
atural course of ruptured plaques in nonculprit lesions in
iving patients.
ETHODS
atient population. Between September 1998 and
ecember 2003, 327 patients were analyzed by coronary
ngioscopy. Thirty consecutive patients in whom two or
hree de novo native coronary arteries were evaluated by
epeat angioscopic procedures and who had ruptured
laque(s) at nonculprit lesions were enrolled in this study.
ritten, informed consent approved by our institutional
eview boards was obtained from all study patients before
atheterization.
linical demographics. The patient demographics were
btained by a hospital chart review. Stable angina pectoris
as defined as a positive stress test and no change in the
requency, duration, or intensity of symptoms lasting 4
eeks. Unstable angina pectoris (UAP) was new-onset
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March 1, 2005:652–8 Angioscopy of Nonculprit Plaquesevere angina, accelerated angina, or rest angina. Acute or
ecent MI occurred within6 weeks, and a previous MI6
eeks. Patients with UAP, acute MI, and recent MI were
ategorized as ACS. Blood sampling was collected in the
asting state, immediately before each angioscopic proce-
ure, except for CRP in patients with ACS. In ACS, the
erum CRP level four weeks after onset was selected as the
aseline level because of exclusion of the effects of myocar-
ial necrosis.
A culprit lesion was identified by the combination of the
lectrocardiographic findings, left ventricle wall motion
bnormalities (left ventriculography or echocardiography),
cintigraphic defects, and angiographic lesion morphology.
ngiographic analysis. All angiograms were analyzed with
computer-assisted, automated edge-detection algorithm
CMS, MEDIS, Nuenen, The Netherlands) by an angiog-
apher blinded to the clinical and angioscopic findings,
sing a standard qualitative definition and quantitative
oronary angiographic (QCA) measurements. The variabil-
ty of the QCA measurements was analyzed repeat mea-
urements of the target plaques. The variation in minimal
umen diameter was 0.09  0.09 mm and that in %DS was
.8  2.1%. A follow-up angiogram was obtained at the
ame angle as that in the baseline study.
ngioscopic imaging. The coronary angioscopic proce-
ure has been previously reported (15). The proximal
egments to the culprit lesion were observed by angioscopy
efore PCI for avoidance of mechanical damage due to the
CI procedure. The distal segments to the culprit lesion and
he other coronary arteries were examined after PCI. The
ngioscopic and fluoroscopic images during the angioscopic
bservations were recorded on digital videotape for later
Abbreviations and Acronyms
ACS  acute coronary syndrome
CRP  C-reactive protein
%DS  percent diameter stenosis
IVUS  intravascular ultrasound
LAD  left anterior descending coronary artery
LCx  left circumflex artery
MI  myocardial infarction
PCI  percutaneous coronary intervention
QCA  quantitative coronary angiogram
RCA  right coronary artery
SAP  stable angina pectoris
UAP  unstable angina pectorisigure 1. Angioscopic images of nonculprit ruptured plaques. (A) Yellow plaqu
arrow). (C) Yellow plaque with an ulceration (arrow) and red thrombus. (D)nalysis. The exact position of the angioscopic catheter at
he site of the target plaque was recorded on an angiogram
o ensure a reliable comparison.
efinition and analysis of angioscopic findings. A rup-
ured plaque was defined as a complex plaque and/or a
uperimposed thrombus. A complex plaque was considered
o be present when the surface of the lesion had an irregular
ppearance, including a fissure, flap, and ulceration. Based
n the surface color, the plaque was classified as either
ellow or white. A fissure was defined as a torn intima
ithout floating into the lumen; a flap was a disrupted
ragment floating into the lumen; and ulceration was a
rater-like lesion suggesting a gap in the vessel wall (Fig. 1).
thrombus was defined as a coalescent red or pinkish-
hite, superficial, or protruding mass adhering to the vessel
urface, but clearly a separate structure that remained
espite being flushed with saline solution. Complete plaque
ealing was defined as a covering by the neointima and the
isappearance of thrombus and complex plaque.
The intra-observer agreement on angioscopic images was
easured by having an observer repeat assessment of 20
mages (presented in random order) after one week. The
nter-observer agreement was measured by comparing the
ssessment of 100 images by the two observers blinded to
he clinical background. The intra-observer agreements for
he evaluated angioscopic items (complex plaque, yellow
laque, and thrombus) were 95%, 95%, and 100%, respec-
ively. The inter-observer agreements of those items were
3%, 98%, and 97%, respectively. The kappa values for
ntra-observer agreement of them were 0.94, 0.99, and 0.95,
espectively. The kappa values for inter-observer agreement
f them were 0.95, 0.96, and 0.94, respectively. When there
as any discordance between the two observers, a third
nvestigator read the images, and a consensus was obtained.
ercutaneous coronary intervention and clinical follow-
p. The PCI was performed for only the culprit lesions
sing a stent. Two kinds of antiplatelet agents—ticlopidine
200 mg/day) or cilostazole (200 mg/day), added to aspirin
81 to 200 mg/day)—were administered for at least six
onths. Glycoprotein IIb/IIIa inhibitors have not been
pproved for clinical use in Japan. Repeat PCI, bypass
urgery, ACS, and death were all considered to be major
utcome events.
tatistical analysis. Statistical analysis was performed with
tatView 5.0 (SAS Institute, Cary, North Carolina). Cat-
gorical variables are presented as frequencies and comparede with a fissure (arrow) and red thrombus. (B) Yellow plaque with a flap
Yellow plaque with a pinkish-white thrombus (arrow).
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Angioscopy of Nonculprit Plaques March 1, 2005:652–8y the Fisher exact test. Continuous quantitative data are
resented as the mean value  SD. Continuous data were
ompared by the unpaired Student t test between the
ifferent categories and by the paired Student t test between
he baseline and follow-up. Univariate logistic regression
nalysis was tested to determine clinical predictors for the
ealing of nonculprit ruptured plaques. Variables that
chieved a significance of levels in a univariate logistic
egression analysis were then selected for testing in a
ultivariate logistic regression analysis. A p value of 0.05
as considered to be statistically significant.
ESULTS
linical characteristics at baseline. The clinical character-
stics of 30 patients at baseline are summarized in Table 1.
oronary angioscopy was performed in 73 arteries (2.4 arter-
es/patient): 25 right coronary arteries (RCA), 26 left anterior
escending coronary arteries (LAD), and 22 left circumflex
rteries (LCx).
esion characteristics at baseline. A total of 50 ruptured
laques were found in 36 arteries (19 in RCA, 8 in LAD, 9
n LCx). The lesion characteristics of the ruptured plaques
re summarized in Table 2. The number of ruptured plaques
n nonculprit lesions ranged from one to four per patient
1.67/patient) and 0.68/artery. The %DS of ruptured
laques was 16.3  9.7%. Twenty-five (50%) of 50 plaques
able 1. Patient Characteristics at Baseline (n  30)
ge (yrs) 59.3  9.1
ender, male 25 (83%)
isk factors for atherosclerosis
Diabetes mellitus 8 (27%)
Hypertension 17 (57%)
Hyperlipidemia 27 (90%)
Cigarette smoking 22 (73%)
Obesity 11 (37%)
Family history 6 (20%)
iagnosis for ischemic heart disease
Acute coronary syndrome 17 (57%)
Previous myocardial infarction 10 (33%)
Stable angina pectoris 3 (10%)
ocation of PCI vessel
Right coronary artery 10 (33%)
Left descending artery 12 (40%)
Left circumflex artery 8 (27%)
umber of diseased vessel(s)
1 14 (47%)
2 15 (50%)
3 1 (3%)
erum LDL-C level (mg/dl) 151  31
erum CRP level (mg/dl) 0.22  0.22
umber of ruptured plaques in nonculprit lesions
1 19 (63%)
2 4 (13%)
3 5 (17%)
4 2 (7%)
ata are presented as the mean value  SD or number (%) of patients.
CRP C-reactive protein; LDL-C low-density lipoprotein cholesterol; PCI
ercutaneous coronary intervention.ere recognized as complex lesions on the angiograms. Dorty-eight ruptured plaques (96%) were accompanied by
uperimposed thrombi, and 56% were red thrombi. No
uperimposed thrombi could be detected in each plaque
ith a fissure and flap. There were 13 plaques in which the
nderlying ruptures were not visualized due to the super-
mposed thrombi. Forty-six ruptured plaques (92%) were
iagnosed to be yellow plaques.
able 3. Lesion Characteristics at Follow-Up
Healed
Plaques
(n  15)
Nonhealed
Plaques
(n  35)
istribution of ruptured plaques
Right coronary artery 8 (53%) 19 (54%)
Left anterior descending artery 6 (40%) 7 (20%)
Left circumflex artery 1 (7%) 9 (26%)
ngiographic measurements
Reference diameter (mm) 3.05  0.45 3.07  0.64
Minimal lumen diameter (mm) 2.53  0.59 2.62  0.63
Percent diameter stenosis 22.7  11.6 19.1  12.0
ngiographic morphology
Wall irregularity 2 (13%) 9 (26%)
Haziness or filling defect 1 (7%) 8 (23%)
Ulceration 1 (7%) 1 (3%)
No complexity 11 (73%) 17 (51%)
ngioscopic findings
Thrombus 0 35 (100%)
Red — 6 (17%)
Pinkish-white — 29 (%)
Plaque
Yellow plaque 7 (47%) 34 (97%)
Fissure 0 16 (46%)
Flap 0 4 (11%)
Ulceration 0 2 (6%)
able 2. Lesion Characteristics at Baseline
uptured Plaques in Nonculprit
Lesions n  50
istribution of ruptured plaques
Right coronary artery 27 (54%)
Left anterior descending artery 13 (26%)
Left circumflex artery 10 (20%)
ngiographic measurements
Reference diameter (mm) 3.07  0.58
Minimal lumen diameter (mm) 2.63  0.58
Percent diameter stenosis 16.3  9.7
ngiographic morphology
Wall irregularity 11 (22%)
Haziness or filling defect 12 (24%)
Ulceration 2 (4%)
No complexity 25 (50%)
ngioscopic findings
Thrombus 48 (96%)
Red 28 (56%)
Pinkish-white 20 (40%)
Plaque
Yellow plaque 46 (92%)
Fissure 22 (44%)
Flap 9 (18%)
Ulceration 6 (12%)
ata are presented as the mean value  SD or number (%) of lesions.ata are presented as the number (%) of lesions or mean value  SD.
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March 1, 2005:652–8 Angioscopy of Nonculprit Plaquesesion characteristics at follow-up. Follow-up angios-
opy was performed 13  9 months after the baseline
tudies to document the changes in the nonculprit ruptured
laques that had been previously identified. At follow-up,
5 thrombi still remained on the same plaques at baseline
Table 3). The frequency of red thrombi decreased to 17%,
nd pinkish-white thrombi became predominant. Fifteen
uptured plaques in 11 patients healed completely (Fig. 2),
nd the overall healing rate of the plaque was 30%. The
requency of yellow plaques in the healed plaques was 47%.
he healing rate of the plaque increased according to the
ollow-up period (23% [9 of 39] at 12 months vs. 55% [6
f 11] at 12 months, p  0.044) (Fig. 3).
On QCA analysis, the %DS of the healed plaques at
ollow-up was greater than that at baseline (22.7  11.6% vs.
2.3  5.8%; p  0.0004), whereas that of nonhealed plaque
as not significantly different between that at follow-up and
aseline (19.1  12.0% vs. 18.0  10.6%; p  0.6).
linical characteristics at follow-up. In 29 patients, all
laques in the same patient could be categorized as either
ealed or not. One patient who had both two healed plaques
nd one residual ruptured plaque was excluded from the
ollowing analysis. The clinical characteristics at follow-up
n patients with healed plaques (n  10) and in those
ithout healed plaques (n 19) are summarized in Table 4.
he frequency of statin use in patients with healed plaques
as higher than that in those without healed plaques (p 
.009). In patients with healed plaques, the serum CRP
evel did not change significantly from 0.24 0.34 mg/dl at
aseline to 0.07  0.03 mg/dl at follow-up (p  0.16). The
igure 2. Healing of nonculprit plaque in acute coronary syndrome (ACS
CS. (B)A pinkish-white thrombus on the yellow plaque was observed in t
ollow-up coronary angiogram in the same patient. (D) The thrombus disa
uantitative coronary angiogram measurements, %DS at the angioscopic i
3.1% at follow-up.erum CRP level in patients with healed plaque was lower
r
fhan that in those without healed plaques (0.07 
.03 mg/dl vs. 0.15  0.11 mg/dl; p  0.007).
The results of univariate logistic regression analyses
ndicated that the serum CRP level at follow-up and statin
se were predictors for plaque healing in nonculprit lesions
Table 5). Multivariate logistic regression analysis was
erformed, in which the serum CRP level at follow-up and
tatin use were the independent variables. Two clinical
ariables were not statistically significant (serum CRP level
t follow-up: p  0.12, odds ratio 1.21, 95% confidence
nterval 0.99 to 1.62; statin use: p  0.19, odds ratio 0.27,
5% confidence interval 0.04 to 1.83).
Coronary angiogram of the left circumflex artery (LCx) in a patient with
d-portion of the LCx at baseline (white arrowhead in A). (C)A 12-month
ed and a smooth white intima was found (white arrowhead in C). In the
site (white arrowhead in A and C) increased from 34.5% at baseline to
igure 3. Relationship between the angioscopic follow-up period and
ealing rate of the nonculprit ruptured plaques. The healing rate of
uptured plaques of 12 months and 12 months were 23% and 55%,). (A)
he mi
ppear
mageespectively. The healing rate increased according to the angioscopic
ollow-up period.
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Angioscopy of Nonculprit Plaques March 1, 2005:652–8linical events. All patients underwent successful PCI for
ulprit lesions at baseline. The clinical follow-up period was
8  16 months. Five patients underwent repeat PCI for
estenosis at three to six months after baseline. A new onset
f effort angina (SAP) occurred in one patient 25 months
fter baseline. In this patient, a healed plaque confirmed by
ngioscopy showed progression on an angiogram, and PCI
as performed. All patients were free from bypass surgery,
CS, and death during the clinical follow-up period.
ISCUSSION
ultiple coronary plaque ruptures, including culprit plaque
nd other plaques, can occur in patients with various
schemic heart disease (6–10). At the present time, ruptured
laque in the culprit lesion is commonly treated by PCI.
his follow-up study clarified the changes in ruptured
laques in nonculprit lesions.
hange of thrombus color and plaque healing. A previ-
us IVUS study reported the frequencies of thrombus in
onculprit ruptured plaques in ACS and in non-ACS to be
2% and 8%, respectively (8). In this angioscopic study, 48
96%) of 50 ruptured plaques were associated with super-
mposed thrombi. Coronary angioscopy might be superior
o IVUS regarding its ability to differentiate plaque from
hrombus. Moreover, angioscopy can show the thrombus
olor, which allows us to estimate the age and components
f the thrombus. In this study, the predominant thrombus
olor changed from red at baseline to pinkish-white at
ollow-up. A red thrombus on angioscopy is considered to
e a fresh one and is mainly composed of red blood cells and
Table 4. Patient Characteristics at Follow-Up
H
Serum LDL-C level (mg/dl)
Changes in serum LDL-C level (mg/dl)
Serum CRP level (mg/dl)
Medication
Antiplatelet
Warfarin
Angiotensin-converting enzyme inhibitor
Angiotensin receptor blocker
Beta-blocker
Statin
Data are presented as the mean value  SD or number (%)
Abbreviations as in Table 1.
able 5. Predictors for the Healing of Nonculprit Ruptured
laques
p
Value
Odds
Ratio 95% CI
erum LDL-C level at follow-up 0.057 1.03 0.99–1.06
hanges in serum LDL-C level 0.151 1.01 1.00–1.04
erum CRP level at follow-up 0.004 1.28 1.06–1.68
tatin use 0.010 0.11 0.02–0.60cI  confidence interval; other abbreviations as in Table 1.brin. In the process of thrombus organization, a red
hrombus changes into a pinkish-white one with platelets
nd fibrin formation (3,16). Our observations on the
hanges in thrombus color might show the process of
hrombus organization.
In our study, the angioscopic follow-up period varied.
owever, the frequency of disappearance of thrombus and
ealed plaque increased gradually according to the
ollow-up period. The frequency of yellow plaques in the
ealed plaques was lower than that at baseline. In several
ases, the plaque color changed from yellow to white during
he healing process. Similar to the healing of culprit plaques
fter PCI, a white neointima on angioscopy may cover the
onculprit ruptured plaques and also play a role in the repair
rocess (17). Surprisingly, several thrombi were still found
n the ruptured plaque after 12 months of follow-up. These
esults may suggest that ruptured plaques heal very slowly. A
revious pathologic study demonstrated that repetitive rup-
ures occur in the healed plaques (10). Perhaps part of the
hrombi form after recurrent ruptures, and repetitive rup-
ures could not be excluded in our study.
hange in angiographic stenosis. The %DS of the healed
laques increased significantly from baseline to follow-up. A
ostmortem study in patients with sudden cardiac death
eported that the area within the internal elastic lamina is
ess in healed plaque after a subclinical rupture than in acute
uptured plaque (10). Furthermore, a cellular proliferation
f smooth muscle cells is higher at healed plaque than at
uptured plaque (10). These facts suggest that plaque
ealing results in an increased plaque burden and negative
emodeling.
Our past combination study using angioscopy and IVUS
evealed that nondisrupted white plaque and negative re-
odeling are often found in the culprit lesions of SAP (18).
robably, in several cases of SAP, stenosis of the coronary
umens developed, and clinical symptoms have appeared in
he process of plaque healing after previous ruptures. The
recise mechanism of angiographic progression was not
ts With
Plaques
 10)
Patients Without
Healed Plaques
(n  19) p Value
 28 128  31 0.13
 50 24  37 0.15
 0.03 0.15  0.11 0.007
100%) 19 (100%) 0.99
0 1 (5%) 0.46
50%) 6 (32%) 0.33
30%) 5 (26%) 0.83
20%) 6 (32%) 0.51
70%) 4 (21%) 0.009
ients. The Fisher exact test was used for categorical data.Patien
ealed
(n
109
51
0.07
10 (
5 (
3 (
2 (
7 (larified in this angioscopic study, although progression of
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March 1, 2005:652–8 Angioscopy of Nonculprit Plaqueshe healed plaques might have resulted from negative
emodeling and cell infiltration into the plaques.
erum CRP level. The serum CRP level predicts the risk
f MI or stroke better than total and low-density lipoprotein
holesterol levels (12). A previous angiographic study re-
ealed the presence of multiple complex stenosis in ACS
atients, and such stenosis was found to correlate with
levated CRP levels (19). In our study, the serum CRP level
n patients with healed plaques did not significantly decrease
rom baseline to follow-up. The serum CRP level in
atients with healed plaques was lower than that in those
ithout healed plaques, thus suggesting that the serum
RP level should reflect the disease activity of the plaque
uptures.
Pharmacologic intervention with statin therapy has been
hown to reduce the serum CRP level. We previously
eported that statin therapy reduces the serum CRP level
nd angioscopic complexity of the plaques (the existence of
he thrombus and the irregularity of the plaque) in noncul-
rit lesions (20). Our present data show that frequency of
dministration of a statin in patients with healed plaques
as significantly higher than that in those without healed
laques. Moreover, the serum CRP level in patients with
ealed plaques was lower than that in those without healed
laques. Our results from univariate logistic regression
nalyses indicated that both statin therapy and serum CRP
evel at follow-up are considered predictors of healing in
onculprit ruptured plaques. However, a multivariate logis-
ic regression analysis showed that neither statin therapy nor
erum CRP level at follow-up is an independent predictor of
laque healing. These results should be explained so that
hese two factors correlate to each other.
linical events. In this study, no patients had any ACS
vents during the 38-month follow-up without PCI for
onculprit ruptured plaques. A previous angiographic study
n ACS patients with complex coronary lesions demon-
trated a poor clinical prognosis, particularly in terms of
ecurrent ACS episodes (21). On the other hand, an IVUS
tudy of multiple coronary ruptures revealed no recurrence
f ACS during 10-month clinical follow-up (6). In the same
tudy, the stenosis of ruptured plaques in nonculprit lesions
as less severe than that in culprit lesions (39% vs. 70%,
espectively). In our study, the %DS was only 16.3% in
uptured plaques of baseline and 19.1% in nonhealed
laques of follow-up. A quantitative cross-sectional analysis
y IVUS revealed that ruptured plaques at nonculprit
esions have larger lumens than do culprit lesions (6,8). Such
vidence indicates that a plaque rupture itself does not
lways result in acute ischemic events. Our follow-up study
uggests that even though there are residual ruptured
laques and thrombi, the associated lesions do not lead to
he development of ACS in cases with large coronary
umens.
However, an important question remains. Angiographic
tudies have shown that preexisting stenoses of the culprit
esions were previously mild to moderate (22,23). It ismpossible to explain that the degree of stenosis on the
ngiogram can help determine whether the patient develops
CS or the plaque ruptures remain asymptomatic. When
atients have a systemic or local increased potential of
hrombogenicity, ruptured plaques in lesions with mild to
oderate stenosis may lead to ACS (24). Several IVUS
tudies have demonstrated that culprit lesions of ACS have
greater plaque burden than do ruptured plaques in
onculprit lesions (6–8). In the event of a plaque rupture, a
arge plaque is considered to contribute to accelerated local
hrombogenicity and the development of thrombosis be-
ause of the exposure of a large amount of its contents, such
s tissue factor and collagen (25). Conversely, at the
onculprit plaques in smaller sized plaques, even though
hrombi still remain, growth of the thrombi may be limited.
herefore, both the degree of stenosis and plaque size,
hich are unable to be validated by an angiogram, may thus
e determinant factors in the clinical course of ruptured
laques.
Atherosclerosis is a progressive disease. Repetitive coro-
ary plaque ruptures on the healed plaques can occur, and
hen the degree of luminal narrowing should progress (10).
significant degree of stenosis thus appears to be associated
ith the cause acute thrombotic events (26). Further
ollow-up studies are needed to examine the development of
evere stenosis and acute coronary events.
tudy limitations. The number of analyzed plaques and
atients represent a limitation of this study. Coronary
ngioscopy was not performed in all segments of coronary
rteries in all patients. Some selection bias is therefore
nevitable, beginning with the selection of patients to
ndergo cardiac catheterization and angioscopy. The
ollow-up angioscopic examination, which was performed at
single time point, also has some limitations.
onclusions. This follow-up study documented that
laque ruptures in nonculprit lesions tend to heal slowly
ith a progression of luminal stenosis, and the serum CRP
evel might reflect the disease activity of the plaque ruptures.
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